Read The Fine Print: China's New Data Protection Plan Has Some Catches
China SDA's newest proposal gives six and 12 years' data protection for innovative new drugs and therapeutic biologics, respectively, but certain terms and conditions apply.
You may also be interested in...
China officially issues regulation accepting clinical data obtained from overseas studies, with a priority on treatments for critical, rare and pediatric conditions.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.